This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Clinical Trial of the Optimal Endpoint of Early Sepsis Resuscitation (LactATES)

This study has been completed.
Information provided by:
National Institute of General Medical Sciences (NIGMS) Identifier:
First received: September 6, 2006
Last updated: January 12, 2009
Last verified: January 2009
The purpose of this study is to determine if there is equivalence between two different methods of treating patients with severe bloodstream infection called sepsis. We will randomly assign patients to one of two treatment methods. One of the treatment methods is the current standard of care and uses an infrared sensor on the end of a catheter to determine the adequacy of treatment. The second treatment method is identical to the first but instead of the infrared sensor a blood test that is performed as a part of standard care (with blood drawn from the catheter) will be used to determine the adequacy of treatment. This study will attempt to determine an easier method of guiding treatment.

Condition Intervention
Severe Sepsis Septic Shock Procedure: Modified EGDT Procedure: Standard EGDT

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Lactate Assessment in the Treatment of Early Sepsis: The LactATES Trial

Resource links provided by NLM:

Further study details as provided by National Institute of General Medical Sciences (NIGMS):

Primary Outcome Measures:
  • Mortality [ Time Frame: In-hospital ]

Enrollment: 300
Study Start Date: January 2007
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1 Procedure: Standard EGDT
Early goal directed therapy
Experimental: 2 Procedure: Modified EGDT
Early goal directed therapy with lactate clearance


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Suspected infection
  2. Any two of four criteria of systemic inflammatory response
  3. SBP < 90 mm Hg after 20cc/kg crystalloid (septic shock) or either a whole blood lactate > 4 mmol/L (severe sepsis).

Exclusion Criteria:

  1. Age < 18 years
  2. Pregnancy
  3. Established "Do Not Resuscitate" orders prior to enrollment
  4. Primary diagnosis other than sepsis
  5. Requirement for immediate surgery in < 6 hours from admission
  6. Any absolute contraindication to central venous catheterization
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00372502

United States, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
United States, New Jersey
Cooper Hospital
Camden, New Jersey, United States
United States, North Carolina
Carolinas Medical Center
Charlotte, North Carolina, United States
Sponsors and Collaborators
National Institute of General Medical Sciences (NIGMS)
Study Director: Alan E Jones, MD Carolinas Medical Center
Study Chair: Jeffrey A Kline, MD Carolinas Medical Center
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Alan E Jones, MD; Assistant Research Director, Carolinas Medical Center Identifier: NCT00372502     History of Changes
Other Study ID Numbers: 1K23GM076652 ( U.S. NIH Grant/Contract )
Study First Received: September 6, 2006
Last Updated: January 12, 2009

Keywords provided by National Institute of General Medical Sciences (NIGMS):
emergency department

Additional relevant MeSH terms:
Shock, Septic
Systemic Inflammatory Response Syndrome
Pathologic Processes
Shock processed this record on August 23, 2017